🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00417053
Treatments Being Tested
This is a Phase II, open-label, two strata, multicenter, prospective study ...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2013-05
Trial ID
NCT01696461
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
The purpose of this study is to determine the safety and effectiveness of U...
Status
Completed
Location
Texas Children's Hospital
Start Date
2009-09
Trial ID
NCT00950846
Treatments Being Tested
The purpose of the study is to assess the safety and efficacy of haploident...
Status
Unknown
Location
First Affiliated Hospital of Guangxi Medical University
Start Date
2017-04-01
Trial ID
NCT03171831
The purpose of this prospective phase III, open-label, randomized multicent...
Status
Completed
Location
Chaim Sheba Medical Center
Start Date
2008-01
Trial ID
NCT01191957
Treatments Being Tested
This phase II trial studies if itacitinib plus standard of care treatment m...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-01-11
Trial ID
NCT04859946